Literature DB >> 12243205

To tell or not to tell: on disclosing the diagnosis of dementia.

Gill Pinner1, Walter Pierre Bouman.   

Abstract

Research suggests there has been a cultural change in the disclosure of diagnosis with most evidence held in cancer literature. This article reviews how disclosure of diagnosis relates to the field of dementia. Practitioners' attitudes and practice are being discussed, as are the attitudes and views of carers, peer groups, and patients. Practitioners show great variations in practice, with only around 50% of clinicians regularly telling patients with dementia their diagnosis. The majority of carers also appear to prefer the diagnosis to be withheld from the patient with dementia. However, most practitioners and carers would wish to know themselves if they had the illness. Although in contrast, studies on the views of elderly peer groups show that the vast majority wishes to be fully informed, views of patients with dementia regarding the area of disclosure are still lacking. Factors influencing the decision to disclose the diagnosis, including the degree of certainty of the diagnosis of dementia, the degree of insight of the patient, and the severity of the dementia, are investigated. The advantages and disadvantages of disclosure and the ethical issues are examined, as well as when or whether and how to disclose the diagnosis of dementia. Flexible guidelines regarding the process of disclosure are introduced.

Entities:  

Mesh:

Year:  2002        PMID: 12243205     DOI: 10.1017/s1041610202008347

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  10 in total

Review 1.  [On disclosing a diagnosis of dementia].

Authors:  G Lämmler; E Stechl; E Steinhagen-Thiessen
Journal:  Z Gerontol Geriatr       Date:  2007-04       Impact factor: 1.281

2.  Difficulties in disclosing the diagnosis of dementia: a qualitative study in general practice.

Authors:  Jill Phillips; Constance Dimity Pond; Nerida Elizabeth Paterson; Cate Howell; Allan Shell; Nigel P Stocks; Susan M Goode; John E Marley
Journal:  Br J Gen Pract       Date:  2012-08       Impact factor: 5.386

Review 3.  Mild cognitive impairment: conceptual, assessment, ethical, and social issues.

Authors:  Perla Werner; Amos D Korczyn
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

4.  Balancing the use of language to enable care: a qualitative study of oral and written language used in assessments and allocations of community healthcare services for persons with dementia.

Authors:  Anette Hansen; Solveig Hauge; Ådel Bergland
Journal:  BMC Health Serv Res       Date:  2016-08-16       Impact factor: 2.655

Review 5.  Capacity issues and decision-making in dementia.

Authors:  Soumya Hegde; Ratnavalli Ellajosyula
Journal:  Ann Indian Acad Neurol       Date:  2016-10       Impact factor: 1.383

Review 6.  SPIKES-D: a proposal to adapt the SPIKES protocol to deliver the diagnosis of dementia.

Authors:  Vanessa Giffoni de Medeiros Nunes Pinheiro Peixoto; Rosiane Viana Zuza Diniz; Clécio de Oliveira Godeiro
Journal:  Dement Neuropsychol       Date:  2020-12

7.  Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.

Authors:  Bryan M McClarty; Daniel W Fisher; Hongxin Dong
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-15

8.  General practitioner's clinical practices, difficulties and educational needs to manage Alzheimer's disease in France: analysis of national telephone-inquiry data.

Authors:  Dominique Somme; Arnaud Gautier; Stéphanie Pin; Aline Corvol
Journal:  BMC Fam Pract       Date:  2013-06-13       Impact factor: 2.497

9.  Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing.

Authors:  Elizabeth A McCusker; Clement T Loy
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-06

10.  Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed.

Authors:  Zümrüt Alpinar-Sencan; Silke Schicktanz
Journal:  BMC Med Ethics       Date:  2020-05-11       Impact factor: 2.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.